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Pregnancy-induced 
Hypertension 
“Probably 
linked” to PFOa 
Contamination
Working as part of a class-action legal settle-
ment with DuPont, a science panel appointed 
by the Wood County Circuit Court recently 
announced the first “probable link” between 
perfluorooctanoic acid (PFOA) released into 
the environment from a DuPont manufactur-
ing  plant  and  disease  in  neighboring  com-
munities—specifically,  pregnancy-induced 
hypertension (PIH).
1 The panel was ordered 
to return a “probable link” finding if occur-
rence of a disease in members of the settlement 
class was judged “more likely than not” to be 
increased by the members’ PFOA exposure. 
With this first “probable link” designation, the 
next stage of the settlement kicks in, whereby 
DuPont  must  pay  up  to  $235  million  to 
monitor  class  members  for  any  diseases  for 
which a probable link is determined.
2
PFOA can be released into the environ-
ment  during  the  manufacture  of  products 
such  as  Teflon™  nonstick  coating.  The 
chemical is present in an estimated 98% of 
Americans, with average blood serum levels 
of  5.2  ng/mL  reported  in  the  1999−2000 
National Health and Nutrition Examination 
Survey.
3 For people living in the 6 affected 
Ohio and West Virginia public water districts 
surrounding  DuPont’s  Washington  Works 
plant, serum PFOA levels averaged 32.91 ng/
mL.
4 P F O A  h a d  l e a c h e d  i n t o  g r o u n d w a t e r  
and  contaminated  the  Ohio  River,  tainting 
drinking water supplies.
5 
In  2004  a  settlement  reached  between 
DuPont  and  the  plaintiffs  established  the 
C8 Health Project
6 to study health effects of 
PFOA  exposures  in  communities  surround-
ing  the  plant.  More  than  69,000  affected 
members of the class submitted blood samples 
and completed a health questionnaire during 
2005  and  2006.  Under  the  terms  of  the 
settlement, a C8 Science Panel was established 
to use all scientifically relevant data to deter-
mine whether PFOA is linked to human dis-
eases. Panelists included epidemiologists Tony 
Fletcher, David Savitz, and Kyle Steenland.
Savitz, a professor at Brown University, 
explains that the panel originally envisioned 
using  the  C8  Health  Project  data  and  a 
literature review to report on potential health 
effects but soon realized that although ani-
mal  studies  have  linked  PFOA  to  tumor 
formation,  neonatal  death,  impaired  thy-
roid,  and  lipid  abnormalities,
7,8 few studies 
have evaluated human health effects. So the 
panelists generated their own research from 
the exposed cohort.
In  December  2011  the  panel  submitted 
to the court its first probable link reports on 
reproductive  outcomes  (PIH,  birth  defects, 
miscarriage/still births, and preterm birth/low 
birth weight). For the PIH report, the panel 
relied on 6 studies examining either PIH or 
preeclampsia, a life-threatening condition for 
mother and fetus characterized by protein in 
the urine (proteinuria) combined with PIH. 
The  panelists  conducted  5  of  the  studies 
themselves, with collaborators. 
The  studies  were  unable  to  distinguish 
between  PIH  with  or  without  proteinuria 
because of the data available. Because women 
with preeclampsia by definition have hyper-
tension,  the  panelists  assessed  only  a  link 
between PIH and PFOA. “There were a series 
of studies that pointed variably and modestly 
towards  there  being  an  association,”  Savitz 
says.  “There  were  different  methodological 
limitations in each of them, but in looking 
at the aggregation of them, there really is a 
signal there.” 
Although  it’s  well  established  that  PIH 
and  preeclampsia  can  cause  preterm  birth 
and  stillbirth,  the  panel  concluded  that  the 
available data were insufficient to support a 
“probable link” between PFOA exposure and 
preterm  birth  or  stillbirths/miscarriages,  or 
birth defects, either. “We were careful not to 
claim that there is no impact [on these other 
PIH-related  end  points]—rather,  that  there 
is insufficient evidence to support a probable 
link,” says Fletcher, a professor at the London 
School  of  Hygiene  &  Tropical  Medicine. 
“This  may  be  due  to  clear  evidence  of  no 
effect or insufficient power, and obviously the 
rarer the outcome, the more that low power 
will result in insufficient evidence to declare 
a link.”
The C8 Health Project is one of the largest 
and most comprehensive studies of its kind to 
result from a legal settlement. “The agreement 
. . . resulted in, first, a very large and rapidly 
collected  data  set  by  a  court-appointed  sur-
vey group, and then significant additions to 
understanding the population science related 
to perfluorocarbon exposure by independent 
researchers,” says Alan Ducatman, chairman 
of  community  medicine  at  West  Virginia 
University.  “These  socially  reasonable  out-
comes help . . . everyone by adding to the 
science and being accountable to population 
needs. That is a credit to the settling parties.”
The  panel  released  3  status  reports  in 
December,  one  with  additional  details  on 
the  reproductive  outcomes,
9  one  on  thyroid 
function,
10 and one on serum cholesterol lev-
els.
11 They found a statistically significant drop 
in  LDL  (“bad”)  cholesterol  associated  with 
PFOA declines in individuals following water 
treatment, as well as a significant increase in 
thyroid disease in women with higher PFOA 
levels. Although status reports are used in the 
panel’s final assessments, Fletcher stresses that 
“one  cannot  impute  the  upcoming  probable 
link  decision  from  one  status  report  alone.” 
The  panel  expects  to  release  its  remaining 
“probable link” assessments by July 2012.
Houston-based freelancer Wendee Holtcamp has written for 
Nature,  Scientific  American,  National  Wildlife,  and  other 
magazines.
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Drinking water contaminated with 
PFOA probably contributed to 
pregnancy-induced hyper  tension 
in women living near a DuPont 
plant near Parkersburg, WV.